Focal Segmental Glomerulosclerosis Companies - LARVOL Sigma

Focal Segmental Glomerulosclerosis

Welcome, Profile Billing Logout

25 Mechanisms of Action


Phase N/A 1 2 3 4 Products		0	3										6										9										12										15										18										21										24										27										30



Generic mfg.



Sanofi



Novartis



Biogen



Roche



AbbVie



BMS



CSL Behring



Kyowa Kirin



Ono Pharma



Otsuka



Amgen



Amicus



Asahi Kasei



Astellas



AstraZeneca



Aurinia Pharma



Boehringer Ingelheim



Cancer Research UK



Chinook Therap



Climb Bio



Clinigen



Dimerix



EMD Serono



Eisai



Enliven Therapeutics



FibroGen



Fulcrum Therap



GSK



Goldfinch Bio



Imara, Inc



ImmuNext



Iovance Biotherap



Lee's Pharm



Ligand



Mallinckrodt



Merck (MSD)



Nippon Shinyaku



PDL



Pfizer



Prometheus



Reata



River 3 Renal Corp



Royalty



Simcere



Travere Therap



ValenzaBio



Vera Therap



Vertex



Zenyaku Holdings